A detailed history of Persistent Asset Partners LTD transactions in Ardelyx, Inc. stock. As of the latest transaction made, Persistent Asset Partners LTD holds 92,046 shares of ARDX stock, worth $540,310. This represents 0.35% of its overall portfolio holdings.

Number of Shares
92,046
Holding current value
$540,310
% of portfolio
0.35%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025

BUY
$3.92 - $6.64 $360,820 - $611,185
92,046 New
92,046 $507 Million

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $908M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Persistent Asset Partners LTD Portfolio

Follow Persistent Asset Partners LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Persistent Asset Partners LTD, based on Form 13F filings with the SEC.

News

Stay updated on Persistent Asset Partners LTD with notifications on news.